To extract, you soak the hemp plant in a solvent, such as grain alcohol. After the material soaks, the remaining liquid contains CBD and the other cannabinoids from the pant. Once you evaporate the solvent, the CBD hemp oil remains. The oil is then ready to either consume or add to edible products. Commercial producers have adopted and modified Mr. Simpson’s method. CBD hemp oil producers use ethanol to extract CBD.
The aforementioned entourage effect is the main reason behind the efficacy of whole plant extracts. There are over 100 ‘identified’ compounds in the cannabis plant. While most of these compounds have their own therapeutic benefit, they combine synergistically to provide far better performance than any single compound alone, and that includes CBD. Here are a couple of examples of conditions that benefit from the entourage effect:
With the variety of CBD concentrations and other compounds that hemp offers, full spectrum CBD products can cover all ground. If we were to directly compare the two, scientists point out that full spectrum CBD works with the endocannabinoid system entirely. Isolate products, such as crystal, the highest quality cannabidiol and natural ingredients, and will deliver the most amount of CBD to your system at once. Ultimately, preference is subjective to the user’s condition and system.
Tetrahydrocannabinol is the most abundant cannabinoid in most medical and recreational marijuana strains. However, in hemp THC is a minor constituent and appears only in trace amounts under 0.3% by dry weight, as required by the U.S. government for hemp products. THC mimics the action of anandamide, a neurotransmitter naturally produced in the human body, and binds to CB1 receptors in the endocannabinoid system found mostly in the brain. The extremely low levels of THC in hemp make hemp oil non-psychoactive and safe for all ages to use.
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160